Hoth Therapeutics Stock Investor Sentiment

HOTH Stock  USD 1.50  0.08  5.06%   
Under 62% of Hoth Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Hoth Therapeutics stock suggests that many investors are alarmed at this time. Hoth Therapeutics' investing sentiment shows overall attitude of investors towards Hoth Therapeutics.
  

Hoth Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hoth Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over two months ago at thelincolnianonline.com         
Hoth Therapeutics Receives Notification from Nasdaq Due to Minimum Bid Price Non-Compliance
news
over two months ago at news.google.com         
Hoth Therapeutics faces Nasdaq delisting over stock price - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Eff...
Google News at Macroaxis
over three months ago at thelincolnianonline.com         
Hoth Therapeutics Rating Reiterated by HC Wainwright
news
over three months ago at finance.yahoo.com         
Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimers Treatment and Prepares for Cli...
Yahoo News
over three months ago at news.google.com         
Hoth Therapeutics, Wise Systems Partner To Leverage AI For Drug Discovery - Contract Pharma
Google News at Macroaxis
over three months ago at news.google.com         
Hoth Therapeutics stock climbs on promising preclinical results for its Alzheimers drug - MSN
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Hoth Therapeutics Announces Promising Preclinical Results for Alzheimers Drug HT-ALZ
Yahoo News
over three months ago at zacks.com         
Hoth Stock Up as Lead Drug Heals Skin Toxicities in Cancer Patient
zacks News
over three months ago at finance.yahoo.com         
Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial
Yahoo News
over three months ago at finance.yahoo.com         
Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-As...
Yahoo News
over three months ago at news.google.com         
Hoth Therapeutics assumed with a Buy at EF Hutton - TipRanks
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Linsley Wayne of 25000 shares of Hoth Therapeutics at 0.7548 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Acquisition by Robb Knie of 25000 shares of Hoth Therapeutics at 0.67 subject to Rule 16b-3
Yahoo News
over three months ago at finance.yahoo.com         
Hoth and Aronnax partner for HT-KIT cancer therapy development
Yahoo News
Far too much social signal, news, headlines, and media speculation about Hoth Therapeutics that are available to investors today. That information is available publicly through Hoth media outlets and privately through word of mouth or via Hoth internal channels. However, regardless of the origin, that massive amount of Hoth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hoth Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hoth Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hoth Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hoth Therapeutics alpha.

Hoth Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Hoth Up on Bitcoin Buy - Baystreet.ca
11/20/2024
2
Acquisition by Poor Kevin Jess of 750000 shares of Hoth Therapeutics subject to Rule 16b-3
11/27/2024
3
Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3
12/20/2024
4
Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment
12/26/2024
5
Hoth Therapeutics Soars 215 percent on Breakthrough Cancer Treatment Success
01/07/2025
6
Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3
01/14/2025
7
Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025
01/17/2025

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm